# Blackstone Mortgage Trust, Inc.: financial statements, quarterly

BXMT · NYSE · CIK 1061630 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bxmt.md) · [Financials](/companies/bxmt/financials.md) · [Filings](/companies/bxmt/filings.md) · [Insiders](/companies/bxmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bxmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [351 d](/filings/0001061630-24-000029.md) | [344](/filings/0001061630-24-000064.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.7 d](/filings/0001061630-26-000009.md) | [1.0](/filings/0001061630-25-000054.md) | [1.2](/filings/0001061630-25-000101.md) | [0.6](/filings/0001061630-25-000128.md) | [(0.5) d](/filings/0001061630-26-000009.md) | [0.7](/filings/0001061630-26-000029.md) | [0.9](/filings/0001061630-26-000069.md) | [1.5](/filings/0001061630-26-000097.md) | [0.5 d](/filings/0001061630-26-000009.md) | [1.2](/filings/0001061630-26-000029.md) | [2.5](/filings/0001061630-26-000069.md) | [1.3](/filings/0001061630-26-000097.md) |
| Net income | $m | [(2.4) d](/filings/0001061630-26-000009.md) | [(124)](/filings/0001061630-25-000054.md) | [(61.1)](/filings/0001061630-25-000101.md) | [(56.4)](/filings/0001061630-25-000128.md) | [37.2 d](/filings/0001061630-26-000009.md) | [(0.4)](/filings/0001061630-26-000029.md) | [7.0](/filings/0001061630-26-000069.md) | [63.4](/filings/0001061630-26-000097.md) | [39.6 d](/filings/0001061630-26-000009.md) | [(6.3)](/filings/0001061630-26-000029.md) | [(81.2)](/filings/0001061630-26-000069.md) | [(327)](/filings/0001061630-26-000097.md) |
| Diluted EPS | $ per share | not reported | [(0.71)](/filings/0001061630-25-000054.md) | [(0.35)](/filings/0001061630-25-000101.md) | [(0.32)](/filings/0001061630-25-000128.md) | not reported | [0.00](/filings/0001061630-26-000029.md) | [0.04](/filings/0001061630-26-000069.md) | [0.37](/filings/0001061630-26-000097.md) | not reported | [(0.04)](/filings/0001061630-26-000029.md) | [(0.48)](/filings/0001061630-26-000069.md) | [(1.95)](/filings/0001061630-26-000097.md) |
| Basic EPS | $ per share | not reported | [(0.71)](/filings/0001061630-25-000054.md) | [(0.35)](/filings/0001061630-25-000101.md) | [(0.32)](/filings/0001061630-25-000128.md) | not reported | [0.00](/filings/0001061630-26-000029.md) | [0.04](/filings/0001061630-26-000069.md) | [0.37](/filings/0001061630-26-000097.md) | not reported | [(0.04)](/filings/0001061630-26-000029.md) | [(0.48)](/filings/0001061630-26-000069.md) | [(1.95)](/filings/0001061630-26-000097.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001061630-25-000024.md) | [0.4](/filings/0001061630-24-000064.md) | [0.4](/filings/0001061630-24-000116.md) | [0.3](/filings/0001061630-24-000148.md) | [0.3](/filings/0001061630-26-000009.md) | [0.7](/filings/0001061630-25-000054.md) | [0.4](/filings/0001061630-25-000101.md) | [0.4](/filings/0001061630-25-000128.md) | [0.5](/filings/0001061630-26-000097.md) | [0.5](/filings/0001061630-26-000029.md) | [0.4](/filings/0001061630-26-000069.md) | [0.5](/filings/0001061630-26-000097.md) |
| Total assets | $bn | [24.0](/filings/0001061630-25-000024.md) | [23.3](/filings/0001061630-24-000064.md) | [22.6](/filings/0001061630-24-000116.md) | [21.4](/filings/0001061630-24-000148.md) | [19.8](/filings/0001061630-26-000009.md) | [20.0](/filings/0001061630-25-000054.md) | [20.6](/filings/0001061630-25-000101.md) | [19.7](/filings/0001061630-25-000128.md) | [20.0](/filings/0001061630-26-000097.md) | [19.6](/filings/0001061630-26-000029.md) | [19.4](/filings/0001061630-26-000069.md) | [17.5](/filings/0001061630-26-000097.md) |
| Total liabilities | $bn | [19.6](/filings/0001061630-25-000024.md) | [19.1](/filings/0001061630-24-000064.md) | [18.6](/filings/0001061630-24-000116.md) | [17.6](/filings/0001061630-24-000148.md) | [16.0](/filings/0001061630-26-000009.md) | [16.3](/filings/0001061630-25-000054.md) | [17.0](/filings/0001061630-25-000101.md) | [16.1](/filings/0001061630-25-000128.md) | [16.5](/filings/0001061630-26-000097.md) | [16.2](/filings/0001061630-26-000029.md) | [16.1](/filings/0001061630-26-000069.md) | [14.6](/filings/0001061630-26-000097.md) |
| Long-term debt | $bn | [16.5](/filings/0001061630-24-000029.md) | [16.2](/filings/0001061630-24-000064.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.4](/filings/0001061630-25-000024.md) | [4.1](/filings/0001061630-24-000064.md) | [4.0](/filings/0001061630-24-000116.md) | [3.8](/filings/0001061630-24-000148.md) | [3.8](/filings/0001061630-26-000009.md) | [3.7](/filings/0001061630-25-000054.md) | [3.6](/filings/0001061630-25-000101.md) | [3.6](/filings/0001061630-25-000128.md) | [3.5](/filings/0001061630-26-000097.md) | [3.4](/filings/0001061630-26-000029.md) | [3.3](/filings/0001061630-26-000069.md) | [2.8](/filings/0001061630-26-000097.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [111 d](/filings/0001061630-26-000009.md) | [94.6](/filings/0001061630-25-000054.md) | [100 d](/filings/0001061630-25-000101.md) | [87.1 d](/filings/0001061630-25-000128.md) | [84.5 d](/filings/0001061630-26-000009.md) | [101](/filings/0001061630-26-000029.md) | [57.2 d](/filings/0001061630-26-000069.md) | [(18.2) d](/filings/0001061630-26-000097.md) | [136 d](/filings/0001061630-26-000009.md) | [170](/filings/0001061630-26-000029.md) | [65.2 d](/filings/0001061630-26-000069.md) | [(18.5) d](/filings/0001061630-26-000097.md) |
| Dividends paid | $m | [107 d](/filings/0001061630-26-000009.md) | [107](/filings/0001061630-25-000054.md) | [108 d](/filings/0001061630-25-000101.md) | [108 d](/filings/0001061630-25-000128.md) | [81.3 d](/filings/0001061630-26-000009.md) | [81.2](/filings/0001061630-26-000029.md) | [80.6 d](/filings/0001061630-26-000069.md) | [80.6 d](/filings/0001061630-26-000097.md) | [80.2 d](/filings/0001061630-26-000009.md) | [79.1](/filings/0001061630-26-000029.md) | [79.3 d](/filings/0001061630-26-000069.md) | [79.2 d](/filings/0001061630-26-000097.md) |
| Share repurchases | $m | [0.0 d](/filings/0001061630-26-000009.md) | [0.0](/filings/0001061630-25-000054.md) | [0.0 d](/filings/0001061630-25-000101.md) | [11.0 d](/filings/0001061630-25-000128.md) | [18.2 d](/filings/0001061630-26-000009.md) | [31.6](/filings/0001061630-26-000029.md) | [0.0 d](/filings/0001061630-26-000069.md) | [16.1 d](/filings/0001061630-26-000097.md) | [61.8 d](/filings/0001061630-26-000009.md) | [0.8](/filings/0001061630-26-000029.md) | [3.0 d](/filings/0001061630-26-000069.md) | [36.0 d](/filings/0001061630-26-000097.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [181](/filings/0001061630-24-000064.md) | [181](/filings/0001061630-24-000116.md) | [173](/filings/0001061630-24-000148.md) | [174](/filings/0001061630-25-000054.md) | [174](/filings/0001061630-25-000101.md) | [174](/filings/0001061630-25-000128.md) | [172](/filings/0001061630-26-000029.md) | [172](/filings/0001061630-26-000069.md) | [172](/filings/0001061630-26-000097.md) | [169](/filings/0001061630-26-000029.md) | [169](/filings/0001061630-26-000069.md) | [168](/filings/0001061630-26-000097.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 165,987,923 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001061630-26-000097.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:07 ET. No prices; not investment advice.